MOL2MED
LIVE

Serial Number

97812353

Owner

Crystal Pharmatech Co., Ltd.

Attorney

James J. Bitetto

First Use Date

Jan 11, 2023

Filing Date

Feb 26, 2023

Add to watchlist:

No watchlists yet
View on USPTO

MOL2MED Trademark

Serial Number: 97812353

MOL2MED is a trademark filed by Crystal Pharmatech Co., Ltd. on February 26, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Crystal Pharmatech Co., Ltd. (2 trademarks)

Suite B4-101, Biobay, 218 Xinghu Street,
Suzhou 215123 , CN

Entity Type: 99

Trademark Details

Filing Date

February 26, 2023

Registration Date

Not Registered

First Use Anywhere

January 11, 2023

First Use in Commerce

January 11, 2023

Goods & Services

Chemical analysis; Chemical research; Chemical research services; Conducting of feasibility studies in the field of new technologies; Material testing; Product quality evaluation; Research and development of new products for others; Research in the field of physics; Scientific laboratory services; Technological research in the field of medicine

Filing History

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 30, 2026 RCCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 9, 2025 TCCA
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Dec 9, 2025 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 9, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 9, 2025 REAP
WITHDRAWAL OF ATTORNEY GRANTED
Nov 11, 2025 WOAG
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Nov 11, 2025 WOAR
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 10, 2025 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 9, 2025 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 26, 2025 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 26, 2024 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 5, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 5, 2023 GNSL
SUSPENSION LETTER WRITTEN
Dec 5, 2023 CNSL
ASSIGNED TO EXAMINER
Nov 27, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 16, 2023 NWOS
NEW APPLICATION ENTERED
Mar 1, 2023 NWAP